Fingerprint
Dive into the research topics where Adriaan Volkers is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Research output
-
Evolution of SARS-CoV-2 antibody repertoire after successive mRNA vaccinations under immunosuppressive treatment
T2B! immunity against SARS-CoV-2 study group, Bemelman, F. J. & Hilhorst, M. L., Mar 2025, In: EBioMedicine. 113, p. 105620 105620.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile13 Downloads (Pure) -
Impact of COVID-19 disease and vaccination on dermatological immune-mediated inflammatory diseases atopic dermatitis, psoriasis, and vitiligo: a Target2B! substudy
van Buchem-Post, N. F., Ouwerkerk, W., Stalman, E. W., van Dam, K. P. J., Wieske, L., Bekkenk, M. W., Wolkerstorfer, A., Spuls, P., Musters, A. H., Bosma, A. L., Hijnen, D.-J., Eftimov, F., Luiten, R. M., T2B! immunity against SARS-CoV-2 study group & Hilhorst, M. L., Apr 2025, In: Journal of dermatology. 52, 4, p. 624-633 10 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile19 Downloads (Pure) -
TNF inhibitors affect the induction and maintenance of spike-specific B-cell responses after mRNA vaccination
Kummer, L. Y., Kuijper, L. H., Fernández Blanco, L., Bos, A., Kreher, C., Verstegen, N. J., Duurland, M. C., Konijn, V. A., Jorritsma, T., Tempert, M., Menage, C., Steenhuis, M., van Gils, M. J., Claireaux, M., Garcia-Vallejo, J. J., D'Haens, G. R., Löwenberg, M., Volkers, A. G., van Dam, K. P. & Stalman, E. W. & 9 others, , 4 Aug 2025, In: RMD open. 11, 3, e005724.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile9 Downloads (Pure) -
Clinical and humoral response after SARS-CoV-2 breakthrough infection in patients receiving immunosuppressant therapy
T2B! immunity against SARS-CoV-2 study group, Sept 2024, In: Journal of allergy and clinical immunology. 154, 3, p. 754-766.e7Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile14 Downloads (Pure) -
Cost-effectiveness and cost-utility of optimized mercaptopurine treatment versus placebo in ulcerative colitis patients: The randomized controlled OPTIC trial
Löwenberg, M., van Barreveld, M., Volkers, A., van Gennep, S., Duijvestein, M., van Bodegraven, A. A., Hulshoff, M. S., Jansen, J. M., van Asseldonk, D., West, R., D’Haens, G., de Boer, N. & Dijkgraaf, M. G. W., Nov 2024, In: United European gastroenterology journal. 12, 9, p. 1256-1265 10 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile19 Downloads (Pure)